Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Impedimed Limited ( (AU:IPD) ) has shared an update.
Impedimed Limited has lodged an updated Appendix 2A application with the ASX seeking quotation of new securities under its issuer code IPD. The filing, dated 16 January 2026, corrects information in Part 5 of a previous Appendix 2A submitted the same day, signalling an administrative clarification rather than a change in capital-raising strategy or operational outlook for investors and other stakeholders.
The most recent analyst rating on (AU:IPD) stock is a Buy with a A$0.07 price target. To see the full list of analyst forecasts on Impedimed Limited stock, see the AU:IPD Stock Forecast page.
More about Impedimed Limited
Average Trading Volume: 1,179,706
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$71.34M
For a thorough assessment of IPD stock, go to TipRanks’ Stock Analysis page.